According to the SEC Form 4 filings, Mahony Susan, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $145,017 | 2 | 100 |
| 2026-06-10 | Sale | Axsome Therapeutics, Inc. AXSM | director | 300 0.0006% | $246.18 | $73,854 | -14.3% | |
| 2026-06-09 | Sale | Axsome Therapeutics, Inc. AXSM | director | 300 0.0006% | $237.21 | $71,163 | -13.88% | |
| 2018-04-16 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 34,758 0.0034% | $80.08 | $2.78M | +36.36% | |
| 2018-04-13 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 10,330 0.001% | $80.14 | $827,846 | +37% | |
| 2017-12-04 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 73,170 0.007% | $86.18 | $6.31M | +1.48% | |
| 2016-12-16 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 20,242 0.0018% | $72.65 | $1.47M | +13.86% | |
| 2015-07-28 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 25,000 0.0022% | $84.96 | $2.12M | -5.63% | |
| 2014-07-28 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 2,065 0.0002% | $63.30 | $130,715 | +13.62% | |
| 2014-07-25 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 30,000 0.0027% | $63.90 | $1.92M | +12.81% | |
| 2013-04-29 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 3,500 0.0003% | $56.33 | $197,155 | -4.37% | |
| 2013-03-26 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 5,000 0.0004% | $56.00 | $280,000 | -4.85% | |
| 2013-02-01 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 5,000 0.0004% | $54.28 | $271,400 | -0.61% | |
| 2012-10-24 | Sale | Eli Lilly and Company LLY | SVP & Pres., Lilly Oncology | 10,000 0.0009% | $50.45 | $504,500 | +7.16% |